Holyn Kanake

Policy Agenda

The AI Revolution

We’re in the midst of the biggest technonological revolution since the printing press and nothing matters more than how we craft the policy that guides and governs how it will impact society. In particular:

> Scientific R&D
> Clinical & care delivery
> Media creation & storytelling
> Education & workforce
> and much more

AI as Defense

Biggest exports used to be culture and drugs research. We’ve fallen behind. We must fix:
> R&D funding
> Gov’t contract access
> Direct industry relationship
> IP in post-agentic world
Health data, onshoring manufacturing, detecting bioweapons

Pro-innovation R&D

Increase investment
Improve coordination and direct relationship to startups

Lead clinical trials

Key challenges: Streamlining clinical trails (issues: recruiting subjects, incentive structures)

Tracker

Initiatives

> Genesis Mission
> National Security Commission on Emerging Biotechnology (NSCEB)
> Biotech Caucus

Divisions

> NSF
> HHS (FDA. NIH, ASHF/ARPA‑H)
> DoD (DARPA)
> SBA (SBIR/STTR)

Bills
(Intro’d)

> National Biotech Initiative Act 2025
> National Biotech Safety Act
> Foundation for Enabling Biotechnology Innovation Act
> Independence Investment Fund Act
> Defense Biotechnology Strategy Act
> Biomanufacturing Excellence Act of 2025
> Clinical Trial Modernization Act

RFI

(open) Accelerating the Adoption and Use of AI Clinical Care // HHS
Foundational Innovation and RAPID Engagement (FIRE) // FDA
Partnerships for Transformational AI Models // DOE

Recent AI Updates

02/26 — FDA rejects review of Moderna flu vaccine application
02/26 — Ginkgo & OpenAI autonomous lab
02/26 — Isomorphic eclipses AlphaFold 3 in drug design
01/26 — Life Biosciences gets IND clearance for longevity trials

WINS

BIOSECURE Act included in FY 2026 NDAA

hello@holyn.co